Nuvelution Pharma Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Nuvelution Pharma Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11010
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Nuvelution Pharma Inc (Nuvelution Pharma) is a developer of late-stage clinical assets. The company offers research and development risk-sharing approach to pharmaceutical and biotechnology companies. It facilitates advancement of late-stage clinical assets where research and development budget constraints have delayed their further development. Nuvelution Pharma offers research and development, clinical trial design and execution, financing, human resources services to bring products with significant commercial potential to the market, and allows the companies to maintain commercialization rights. The company serves its clients across the US. Nuvelution Pharma is headquartered in South San Francisco, California, the US.

Nuvelution Pharma Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Nuvelution Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nuvelution Pharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Nuvelution Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nuvelution Pharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Nuvelution Pharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Nuvelution Pharma Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Nuvelution Pharma Raises Funds in Venture Financing 10
Partnerships 11
Nuvelution Pharma Enters into Agreement with Amgen 11
Teva Pharma and Nuvelution Pharma Enter into Agreement 12
Nuvelution Pharma Inc – Key Competitors 13
Nuvelution Pharma Inc – Key Employees 14
Nuvelution Pharma Inc – Locations And Subsidiaries 15
Head Office 15
Recent Developments 16
Corporate Communications 16
Oct 25, 2018: Nuvelution Pharma appoints Kirk ways, M.D., Ph.D., as Chief Medical Officer 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Nuvelution Pharma Inc, Pharmaceuticals & Healthcare, Key Facts 2
Nuvelution Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nuvelution Pharma Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Nuvelution Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nuvelution Pharma Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Nuvelution Pharma Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Nuvelution Pharma Raises Funds in Venture Financing 10
Nuvelution Pharma Enters into Agreement with Amgen 11
Teva Pharma and Nuvelution Pharma Enter into Agreement 12
Nuvelution Pharma Inc, Key Competitors 13
Nuvelution Pharma Inc, Key Employees 14

List of Figures
Nuvelution Pharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Nuvelution Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Nuvelution Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Nuvelution Pharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Nuvelution Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Nuvelution Pharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Nuvelution Pharma Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Nuvelution Pharma Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Nuvelution Pharma Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • HokBen:企業の戦略・SWOT・財務分析
    HokBen - Strategy, SWOT and Corporate Finance Report Summary HokBen - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • ProQR Therapeutics NV (PRQR):企業の財務・戦略的SWOT分析
    Summary ProQR Therapeutics NV (ProQR) is a clinical-stage biotech company that discovers and develops drugs for the treatment of genetic disorders. The company’s lead product candidate includes QR-010, a RNA-based oligonucleotide used for the treatment of cystic fibrosis; QR-110, an oligonucleotide …
  • Yanlord Land Group Ltd:企業の戦略・SWOT・財務分析
    Yanlord Land Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Yanlord Land Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • JB Hi-Fi Limited (JBH):企業の財務・戦略的SWOT分析
    JB Hi-Fi Limited (JBH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Marsulex Environmental Technologies Corp:企業の戦略的SWOT分析
    Marsulex Environmental Technologies Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • U.S. Bancorp:企業の戦略・SWOT・財務情報
    U.S. Bancorp - Strategy, SWOT and Corporate Finance Report Summary U.S. Bancorp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Mitchells & Butlers plc:企業の戦略・SWOT・財務分析
    Mitchells & Butlers plc - Strategy, SWOT and Corporate Finance Report Summary Mitchells & Butlers plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Ergomed Plc (ERGO):製薬・医療:M&Aディール及び事業提携情報
    Summary Ergomed Plc (Ergomed), formerly Ergomed Clinical Research Ltd is a drug development and clinical research services provider. The company provides service portfolio such as regulatory and quality management, biostatistics, study management, clinical data management, medical writing, and other …
  • Petrel Resources Plc (PET):企業の財務・戦略的SWOT分析
    Summary Petrel Resources Plc (Petrel Resources) is an oil and gas company that provides exploration and production of crude oil and natural gas across Iraq. The company provides areas of operations such as Luhais and Subba in Southern Iraq, Tano Basin in Ghana, Porcupine Basin in Ireland, and others …
  • Virgin Islands Water and Power Authority:企業の戦略的SWOT分析
    Virgin Islands Water and Power Authority - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Falck Renewables S.p.A. (FKR):電力:M&Aディール及び事業提携情報
    Summary Falck Renewables S.p.A. (Falck Renewables), formerly Actelios S.p.A that develops, designs, constructs and manages energy production plants. It operates as a subsidiary of Falck S.p.A. The company produces clean energy from various renewable sources including wind energy, solar energy, bioma …
  • Dawnrays Pharmaceutical (Holdings) Ltd (2348):企業の財務・戦略的SWOT分析
    Summary Dawnrays Pharmaceutical (Holdings) Ltd (Dawnrays) is a manufacturer of cephalosporin antibiotics and specific medicines. The company provides products such as cefoperazone sodium and sulbactam sodium sterile, cefoperazone sodium sterile, ceftazidime sterile, cefixme, ceftriaxone sodium crude …
  • Stage Stores Inc:戦略・SWOT・企業財務分析
    Stage Stores Inc - Strategy, SWOT and Corporate Finance Report Summary Stage Stores Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • SK Hynix Inc (000660):企業の財務・戦略的SWOT分析
    SK Hynix Inc (000660) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Turkiye Garanti Bankasi AS:戦略・SWOT・企業財務分析
    Turkiye Garanti Bankasi AS - Strategy, SWOT and Corporate Finance Report Summary Turkiye Garanti Bankasi AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Pt Bakrieland Development Tbk:企業の戦略・SWOT・財務分析
    Pt Bakrieland Development Tbk - Strategy, SWOT and Corporate Finance Report Summary Pt Bakrieland Development Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Accugenomics Inc:企業の製品パイプライン分析
    Summary Accugenomics Inc (Accugenomics) is a developer of oncology molecular diagnostics. The company develops and markets gene expression tests to diagnose and monitor cancer treatment. It offers gene expression tests including lung cancer risk test, standardized BCR-ABL molecular diagnostics test …
  • Exterran Corp (EXTN):石油・ガス:M&Aディール及び事業提携情報
    Summary Exterran Corp (Exterran) is an energy service company that provides compression, production and processing products; and offers services that support the production and transportation of oil and natural gas. The company owns and operates natural gas compression equipment; and crude oil and n …
  • New Brunswick Power Corporation:企業の戦略的SWOT分析
    New Brunswick Power Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Anteo Diagnostics Ltd (ADO):企業の財務・戦略的SWOT分析
    Anteo Diagnostics Ltd (ADO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆